Clinical Trials Logo

Clinical Trial Summary

The long-term goal of our work is to evaluate the effect of intensive postpartum blood pressure control on maternal cardiovascular health, risk of chronic hypertension, and reversal of vascular dysfunction generated by hypertensive disorders of pregnancy, thus attenuating the lifelong trajectory of cardiovascular disease risk.


Clinical Trial Description

The REPAIR trial will randomize 618 postpartum patients with HDP to intensive blood pressure (BP) control with Nifedipine extended release (ER) (target BP <140/90 mmHg) versus active control group (target BP <150/100 mmHg) for 6 weeks postpartum, using home BP monitoring program at two clinical sites: Medical College of Wisconsin (MCW) and Northwestern University (NU). All participants will undergo vascular function assessment: endothelial dysfunction with brachial artery flow mediated dilation (FMD), arterial stiffness with carotid-femoral pulse wave velocity (cfPWV), and collection of an anti-angiogenic biomarker, soluble fms-like tyrosine kinase (sFlt-1), at baseline, 6 weeks, and 12 months postpartum. The primary outcome is the rate of new diagnosis of chronic HTN at one year postpartum. Secondary outcomes are improvement in vascular function, assessed by FMD, cfPWV, and sFlt-1, from baseline to 12 months postpartum. Sub-group analyses will be done to examine study outcomes by HDP type (gestational HTN vs. preeclampsia) and by patients that maintained BP <130/80 mmHg versus higher ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06220721
Study type Interventional
Source Medical College of Wisconsin
Contact Anna Palatnik, MD
Phone 14147916817
Email apalatnik@mcw.edu
Status Not yet recruiting
Phase Phase 3
Start date July 1, 2024
Completion date June 30, 2030

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05999851 - Multiparametric Assessment of Maternal Vascular Function in the Prediction of Hypertensive Disorders of Pregnancy N/A
Recruiting NCT05687344 - Intensive Postpartum Antihypertensive Treatment Phase 3
Recruiting NCT02020174 - The Preeclampsia Registry
Recruiting NCT06377878 - The Preeclampsia Registry
Recruiting NCT05995106 - mHealth for Hypertensive Disorder of Pregnancy N/A
Completed NCT03309826 - Positive Airway Pressure Treatment of Obstructive Sleep-disordered Breathing in Hypertensive Disorders of Pregnancy N/A
Completed NCT05631067 - Feasibility and Acceptability of Risk Stratification in the Fourth Trimester to Reduce Maternal Morbidity and Mortality N/A
Completed NCT03412552 - Risk Analysis of Intensive Care Mangement on Maternal and Fetal Outcome of Severe Preeclampsia and Eclampsia N/A
Completed NCT03728790 - Remote BP Monitoring in the PP Period N/A
Recruiting NCT05089175 - The Investigation of the Prediction Model and Prevention Strategy of Serious Pregnancy Complications in Hypertensive Disorders of Pregnancy Based on the Chinese Population
Recruiting NCT05763069 - HOME: Home Monitoring of High-risk Pregnancies
Recruiting NCT06069102 - Optimal Blood Pressure Treatment Thresholds Postpartum Phase 4
Recruiting NCT05659173 - Vitamin D Deficiency With Selected Vitamin D Receptor Gene Polymorphism in Gestational Hypertension
Not yet recruiting NCT06281665 - Treatment With Aspirin After Preeclampsia: TAP Trial Phase 4
Completed NCT05124327 - Remote Monitoring and Follow-up for Postpartum Hypertensive Disorders of Pregnancy N/A
Recruiting NCT06362356 - Microbial Metabolites and Outcomes of Pregnancy Study
Active, not recruiting NCT04580927 - Breastfeeding and Postpartum Cardiovascular Health N/A
Recruiting NCT05655936 - Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial N/A
Active, not recruiting NCT06019715 - Remote Postpartum Intervention Targeting Movement Behaviors After Hypertensive Disorders of Pregnancy N/A
Recruiting NCT04989634 - Effects of Dietary and Weight Management on Pregnancy Outcomes in Mobile Medical Platform N/A